Consistent with the Western blot findings, Sema3A expression was significantly decreased in the atrial endocardium of patients with AF (Figure 8E) but that Twist and SMA levels were increased (Figure 1, B and C). This evidence concerns the gene SEMA3A and atrial fibrillation.